Table 1. Incidence of adverse events with donor characteristics.
Sample | Adverse events | No adverse events | |
---|---|---|---|
n (%) | n (%) | ||
18,936 | 208 (1.1) | 18,728(98.9) | |
Gender | |||
Male | 18,676 | 205 (1.1) | 18,471(98.9) |
Female | 260 | 3 (1.2) | 257 (98.8) |
χ2 = 0.007, p = 0.931 | |||
Age (years) | |||
<30 | 8,621 | 130 (1.5) | 8491(98.5) |
≥30 | 10,315 | 78 (0.8) | 10,237(99.2) |
χ2 = 24.30, p<0.001* | |||
Weight (Kg) | |||
<75 | 6,019 | 99 (1.6) | 5,920(98.4) |
≥75 | 12,917 | 109 (0.8) | 12,808(99.2) |
χ2 = 24.25, p<0.001* | |||
Donation history | |||
First time donor | 9,010 | 144 (1.6) | 8,866 (98.4) |
Previous donor | 9,926 | 64 (0.6) | 9,862 (99.4) |
χ2 = 39.38, p<0.001* | |||
Hemoglobin level (g/dl) | |||
12.5–13.0 | 440 | 2 (0.5) | 438 (99.5) |
13.1–14.0 | 1,641 | 12 (0.7) | 1,629 (99.3) |
14.1–15.0 | 3,381 | 23 (0.7) | 3,358 (99.3) |
> 15 | 13,474 | 171 (1.3) | 13,303 (98.7) |
χ2 = 12.77, p = 0.005* | |||
Blood pressure | |||
Normal/prehypertensive | 14,860 | 167 (1.1) | 14,693 (98.9) |
Hypertension | 4,076 | 41 (1.0) | 4,035 (99.0) |
χ2 = 0.410, p = 0.522 |
n: frequency,
%: percentage,
χ2: Chi-square,
p: p-value,
*: significance at <0.05, g/dl: gram per deciliter.